A 14-year-old girl presents with a 2-month history of progressive left knee pain and swelling. She reports the pain is worse at night and does not improve with rest or analgesics. On examination, there is a firm, tender mass over the proximal tibia with overlying skin warmth. X-ray shows a mixed lytic and sclerotic lesion in the proximal tibial metaphysis with cortical breakthrough and a 'Codman triangle' periosteal reaction. Serum alkaline phosphatase is 520 IU/L and LDH is 380 U/L. CT chest is normal. Which of the following is the most appropriate next step in management?

Explanation

## Management of Suspected Osteosarcoma ### Clinical Context This patient has imaging and biochemical findings highly suggestive of osteosarcoma. The next step is to confirm the diagnosis with tissue before committing to multimodal therapy. ### Diagnostic Algorithm ```mermaid flowchart TD A[Suspected osteosarcoma on plain X-ray]:::outcome --> B[Perform MRI of primary site]:::action B --> C{Malignancy confirmed on MRI?}:::decision C -->|Yes| D[Tissue biopsy]:::action D --> E{Histology confirms osteosarcoma?}:::decision E -->|Yes| F[Staging: CT chest, bone scan]:::action E -->|No| G[Revise diagnosis]:::action F --> H[Neoadjuvant chemotherapy]:::action H --> I[Surgical resection]:::action I --> J[Adjuvant chemotherapy]:::action J --> K[Surveillance]:::action ``` ### Why MRI + Biopsy? **Key Point:** Tissue diagnosis is mandatory before initiating chemotherapy. MRI is the gold standard for assessing: - Soft tissue extension - Marrow involvement (intramedullary spread) - Neurovascular proximity - Skip lesions **High-Yield:** Biopsy should be performed by the orthopedic surgeon who will perform definitive surgery, using a needle tract that can be excised en bloc with the tumor. ### Imaging Findings Explained | Finding | Significance | |---------|---------------| | Codman triangle | Periosteal reaction where tumor lifts periosteum; periosteum lays bone perpendicular to cortex | | Mixed lytic/sclerotic | Tumor produces osteoid (sclerotic) and destroys bone (lytic) simultaneously | | Cortical breakthrough | Indicates aggressive, rapidly growing lesion breaking through cortex | | Elevated ALP & LDH | Reflects high osteoblastic activity and tumor burden | **Clinical Pearl:** Codman triangle is not pathognomonic for osteosarcoma — it can occur in other aggressive lesions (Ewing sarcoma, hemangioma, infection). However, in this clinical context (age, location, mixed pattern), it strongly supports osteosarcoma. ### Standard Treatment Protocol **Mnemonic: NCSR** — Neoadjuvant chemotherapy, Confirm diagnosis, Surgical resection, Response assessment 1. **Neoadjuvant chemotherapy** (3–4 months) - Drugs: Cisplatin, doxorubicin, methotrexate (MAP regimen) - Allows time for surgical planning and assesses chemosensitivity - Good response (>90% necrosis) predicts better prognosis 2. **Surgical resection** (wide margin, limb-salvage when possible) - Timing: After neoadjuvant therapy response assessment - Margin: 2–3 cm of normal tissue 3. **Adjuvant chemotherapy** (3–4 months) - Same agents as neoadjuvant - Continued if good response to neoadjuvant therapy ### Why NOT the Other Options? **High-Yield:** Starting chemotherapy without tissue diagnosis is unacceptable — the imaging, while highly suggestive, could represent: - Ewing sarcoma (different chemotherapy regimen) - Metastatic disease to bone - Infection or inflammatory lesion Surgical resection without neoadjuvant therapy is outdated and reduces survival. Neoadjuvant chemotherapy downsizes the tumor, allows better surgical planning, and improves limb-salvage rates. [cite:Robbins 10e Ch 26] [cite:NCCN Guidelines: Bone and Soft Tissue Sarcomas]